• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . HIV and SARS CoV-2 Co-Infection: A Retrospective, Record Based, Case Series From South India

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jul 7.
doi: 10.1002/jmv.26271. Online ahead of print.
HIV and SARS CoV-2 Co-Infection: A Retrospective, Record Based, Case Series From South India


Janakiram Marimuthu[SUP] 1 [/SUP], Bubby S Kumar[SUP] 2 [/SUP], P Aravind Gandhi[SUP] 3 [/SUP]



Affiliations

Abstract

HIV prevalence in India is about 0.22%, with the total number of people living with HIV/AIDS (PLHA) is estimated at 21.40 lakhs, constituting third largest epidemic in world. However, no study on HIV-COVID-19 co-infection has been reported from India. We conducted a retrospective, record based case series including three males, 2 females and 1 transgender PLHA co-infected with SARS CoV-2 in the Indian state of Tamil Nadu. Fever (5), followed by cough (2) and sore throat (1), were the presenting symptoms. Latest Median CD4 count among our patients was 535 cells/ mm3. One of the patients was not under clinical HIV control, with an opportunistic infection Two among our patients were having hypertension. The mainstay of treatment given for the patients consisted of multi-vitamins in addition to the ARV drugs, anti-pyretics and anti-tussives. One of the patient was on low dose Ritonavir boosted HAART regimen. All patients had stable vitals at room conditions, did not have any complications during their entire stay in health care facility for COVID-19, treated and discharged. This article is protected by copyright. All rights reserved.

Keywords: Human immunodeficiency virus < Virus classification; Pandemics < Epidemiology; SARS coronavirus < Virus classification.
 
Back
Top Bottom